Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Nuclear Export News

Page 21 - Nuclear Export News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nuclear Export. Real-time updates on events, politics, business and more.

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 1, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
Karyopharm Therapeutics Inc Karyopharm Selective Inhibitor Of Nuclear Export Compensation Committee Of Karyopharm Board Directors European Commission Karyopharm Therapeutics Compensation Committee
Source: prnewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition

November 4, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
United States Eltanexor Monotherapy Praneeth Sudalagunta Suresh Kumar Balasubramanian H Lee Moffitt Yuki Nishida
Source: prnewswire.com

Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition

November 4, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
United States Eltanexor Monotherapy Praneeth Sudalagunta Suresh Kumar Balasubramanian H Lee Moffitt Yuki Nishida
Source: prnewswire.com

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 1, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
Karyopharm Therapeutics Inc Karyopharm Selective Inhibitor Of Nuclear Export Compensation Committee Of Karyopharm Board Directors European Commission Karyopharm Therapeutics Compensation Committee
Source: prnewswire.com

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 1, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
Karyopharm Therapeutics Inc Karyopharm Selective Inhibitor Of Nuclear Export Compensation Committee Of Karyopharm Board Directors European Commission Karyopharm Therapeutics Compensation Committee
Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science